Claris Lifesciences has completed
the transfer of its Infusion business in India and Emerging Markets; to the
joint venture (JV) ‘Claris-Otsuka’; with Otsuka Pharmaceutical Factory, Inc.,
Japan (OPF) and Mitsui & Company, Japan (Mitsui). The Infusion business
includes Common Solutions, Anti-Infective, Plasma Volume Expanders and
Parenteral Nutrition therapies for India and Emerging Markets. 0731-664-2300
No comments:
Post a Comment